Informationen:
Fehler:
ID
29344
Beschreibung
Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male Volunteers; ODM derived from: https://clinicaltrials.gov/show/NCT00937534
Link
https://clinicaltrials.gov/show/NCT00937534
Stichworte
Versionen (1)
- 20.03.18 20.03.18 -
Rechteinhaber
See clinicaltrials.gov
Hochgeladen am
20. März 2018
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Essential Hypertension NCT00937534
Eligibility Essential Hypertension NCT00937534
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Essential Hypertension NCT00937534
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Age
Item
age
boolean
C0001779 (UMLS CUI [1])
Young Adult | Age
Item
young: 19-45 years
boolean
C0238598 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Elderly | Age
Item
elderly: more than 65 years
boolean
C0001792 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Gender
Item
sex: male
boolean
C0079399 (UMLS CUI [1])
Body Weight
Item
body weight: greater than 55 kg
boolean
C0005910 (UMLS CUI [1])
Medical contraindication Angiotensin II receptor antagonist
Item
patients with contraindication to angiotensin ii receptor antagonist.
boolean
C1301624 (UMLS CUI [1,1])
C0521942 (UMLS CUI [1,2])
C0521942 (UMLS CUI [1,2])
Liver diseases | Kidney Diseases | Gastrointestinal Diseases | Hematological Disease | Heart Diseases
Item
patients with a history of liver, renal, gastrointestinal, hematological or cardiac diseases
boolean
C0023895 (UMLS CUI [1])
C0022658 (UMLS CUI [2])
C0017178 (UMLS CUI [3])
C0018939 (UMLS CUI [4])
C0018799 (UMLS CUI [5])
C0022658 (UMLS CUI [2])
C0017178 (UMLS CUI [3])
C0018939 (UMLS CUI [4])
C0018799 (UMLS CUI [5])
Medical History Affecting Absorption Investigational New Drugs | Disease Affecting Absorption Investigational New Drugs
Item
patients with history or diseases which might affect absorption of the drug
boolean
C0262926 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0237442 (UMLS CUI [1,3])
C0013230 (UMLS CUI [1,4])
C0012634 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0237442 (UMLS CUI [2,3])
C0013230 (UMLS CUI [2,4])
C0392760 (UMLS CUI [1,2])
C0237442 (UMLS CUI [1,3])
C0013230 (UMLS CUI [1,4])
C0012634 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0237442 (UMLS CUI [2,3])
C0013230 (UMLS CUI [2,4])
HIV Infection | Hepatitis B | Hepatitis C
Item
patients with hiv, type b or c hepatitis
boolean
C0019693 (UMLS CUI [1])
C0019163 (UMLS CUI [2])
C0019196 (UMLS CUI [3])
C0019163 (UMLS CUI [2])
C0019196 (UMLS CUI [3])
Tobacco use Number of cigarettes per day
Item
smokers of 20 or more cigarettes per day
boolean
C0543414 (UMLS CUI [1,1])
C3694146 (UMLS CUI [1,2])
C3694146 (UMLS CUI [1,2])